CLC Bio Partners with Hoffmann-La Roche, Others on MDx Platform Using FFPE

The $5M project aims to develop a complete platform for selecting FFPE samples, choosing sequencing technology, and then assembling and analyzing the high-throughput sequencing data.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories